2004
DOI: 10.1191/1358863x04vm522oa
|View full text |Cite
|
Sign up to set email alerts
|

Effect of contrast enhancement on measurement of carotid artery intimal medial thickness

Abstract: Previous studies have used standard B-mode ultrasound to quantify the aggregate mean intimal medial thickness (IMT) of the near and far wall of the common carotid artery (CCA). Many investigators have had dif culty in accurately evaluating the near wall IMT secondary to dif culty in discerning the vessel lumen and intima. The purpose of this study is to determine the effect of contrast enhanced ultrasound on IMT measurement when compared with non-enhanced images. Twenty-six patients who had standard carotid ul… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
12
0

Year Published

2006
2006
2018
2018

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(14 citation statements)
references
References 27 publications
2
12
0
Order By: Relevance
“…The positive association we show between the difference in near and far wall IMT and CHD events in our statistical model suggests this possibility. A study looking at the difference between near and far wall noted no difference between near and far wall IMT before ultrasound contrast administration but a significant difference after ultrasound contrast 27 . The significance of this finding is not clear.…”
Section: Discussionmentioning
confidence: 99%
“…The positive association we show between the difference in near and far wall IMT and CHD events in our statistical model suggests this possibility. A study looking at the difference between near and far wall noted no difference between near and far wall IMT before ultrasound contrast administration but a significant difference after ultrasound contrast 27 . The significance of this finding is not clear.…”
Section: Discussionmentioning
confidence: 99%
“…The CECU imaging protocol was performed using an ultrasound contrast agent, Optison™ (perflutren protein type-A microspheres; GE Health Care, Milwaukee, WI, USA) per our standard protocol. 10 Optison is an FDA-approved ultrasound contrast agent that is used for enhancement of the cardiac chambers during echocardiography. In 2000, The American Society of Echocardiography published a guideline manuscript on the use of ultrasound contrast agents.…”
Section: Patient Enrollment and Ultrasound Examination Methodsmentioning
confidence: 99%
“…However, accurate measurements, particularly of the near wall, require a high level of technical expertise. Consequently, some authors suggest the administration of contrast media during the examination period (Macioch et al 2004; Martin and Lekaris 2004). …”
Section: Clinical Assessment Of Endothelial Functionmentioning
confidence: 99%